Live probiotic bacterium (null)

“Live probiotic bacterium” is not a single molecular target but rather refers to **living microorganisms—primarily certain bacteria and yeasts—that confer health benefits when administered in adequate amounts**.[1][3] The most common bacterial genera used as probiotics are *Lactobacillus* (now split into multiple genera), *Bifidobacterium*, *Streptococcus*, *Enterococcus*, *Escherichia* (*E. coli* Nissle), along with the yeast *Saccharomyces boulardii*[3][5]. These organisms act through diverse mechanisms including modulation of the host’s gut microbiome, inhibition or displacement of pathogenic microbes, enhancement/modulation of mucosal immunity, metabolic activity beneficial to the host such as production of vitamins or short-chain fatty acids, and maintenance/restoration of intestinal barrier function.[1][6] Clinical evidence supports their use primarily for prevention/treatment of certain gastrointestinal disorders like acute infectious diarrhea and antibiotic-associated diarrhea; research continues into broader applications across metabolic/inflammatory/immune-mediated diseases.[4] Safety is generally high except among severely immunocompromised individuals where rare adverse events have been reported. The term “live probiotic bacteria” does **not refer to a single molecular target**—it is an umbrella term encompassing many different species/strains across several taxonomic groups.[1] It is therefore **not considered a therapeutic target** like receptors or enzymes would be; it describes whole living organisms rather than discrete molecules/proteins/pathways typically targeted by drugs. For structured data purposes this entry should be flagged as incorrect/not applicable under standard drug-target frameworks.

Other names

Probiotic bacteriaProbioticsLive microorganisms (when referring to probiotics)Lactic acid bacteria (for a major group)Bifidobacteria (for a major group)Saccharomyces boulardii (as an example of yeast probiotic)

Mechanisms vary by strain but commonly include: – Competitive exclusion of pathogens via colonization resistance or coaggregation with pathogens – Production of antimicrobial substances – Modulation of host immune responses – Enhancement/restoration of epithelial barrier integrity – Metabolic effects such as production of short-chain fatty acids